Compare BHST & VGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | BHST | VGI |
|---|---|---|
| Founded | 2007 | 2012 |
| Country | Canada | United States |
| Employees | 89 | N/A |
| Industry | | Investment Managers |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.9M | 83.1M |
| IPO Year | N/A | N/A |
| Metric | BHST | VGI |
|---|---|---|
| Price | $2.90 | $7.48 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | 27.4K | ★ 30.3K |
| Earning Date | 05-15-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 12.66% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $146.27 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.75 | $7.20 |
| 52 Week High | $12.80 | $8.09 |
| Indicator | BHST | VGI |
|---|---|---|
| Relative Strength Index (RSI) | 34.31 | 58.78 |
| Support Level | $2.75 | $7.45 |
| Resistance Level | $3.47 | $7.54 |
| Average True Range (ATR) | 0.24 | 0.07 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 18.27 | 88.00 |
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying these operating segments, management generally follows the Company's service lines representing its main products and services. The Products Business Unit - Nutraceuticals: Research, development, manufacturing, marketing and sales of science-based health and wellness nutraceutical solutions which are manufactured and sold as dietary supplements, functional food and beverages. The CDMO Services Business Unit - comprising a Contract Development and Manufacturing Operation that offers pharmaceuticals, cosmeceuticals, nutraceuticals, and nutritions.
Virtus Global Multi-Sector Inc is a United States based fund. Its investment objective is to maximize current income while preserving capital. The Fund seeks to achieve its investment objective by applying extensive credit research to capitalize on opportunities across undervalued areas of the international bond markets.